Trial intelligence / Profile preview

Multifactorial primary prevention trial in high-risk subjects eligible for lung cancer CT screening

2016-003036-20Phase 2Active

Sponsor

Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano

Start

Jun 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules

Countries

1